XML 182 R99.htm IDEA: XBRL DOCUMENT v3.20.4
Earnings per share (Details)
$ / shares in Units, shares in Millions, $ in Millions
12 Months Ended
Dec. 31, 2020
USD ($)
$ / shares
shares
Dec. 31, 2019
USD ($)
$ / shares
shares
Dec. 31, 2018
USD ($)
$ / shares
shares
Earnings per share [line items]      
Profit/loss attributable to shareholders of Novartis AG | $ $ 8,072 $ 11,732 $ 12,611
Weighted average number of shares outstanding used in the basic earnings per share | shares 2,277 2,291 2,319
Adjustment for vesting of restricted shares, restricted share units and dilutive shares from options | shares 19 28 25
Weighted average number of shares in diluted earnings per share | shares 2,296 2,319 2,344
Basic earnings per share, Continuing operations $ 3.55 $ 3.12 $ 5.52
Basic earnings per share, Discontinued operations   2.00 (0.08)
Total basic earnings per share 3.55 5.12 5.44
Diluted earnings per share, Continuing operations 3.52 3.08 5.46
Diluted earnings per share, Discontinued operations   1.98 (0.08)
Total diluted earnings per share $ 3.52 $ 5.06 $ 5.38
Options excluded from the calculation 0 0 0
Continuing operations [member]      
Earnings per share [line items]      
Profit/loss attributable to shareholders of Novartis AG | $ $ 8,072 $ 7,142 $ 12,797
Discontinued operations [member]      
Earnings per share [line items]      
Profit/loss attributable to shareholders of Novartis AG | $   $ 4,590 $ (186)